4//SEC Filing
Eleven Biotherapeutics, Inc. 4
Accession 0001485003-16-000182
$CARMCIK 0001485003operating
Filed
Sep 21, 8:00 PM ET
Accepted
Sep 22, 5:04 PM ET
Size
7.7 KB
Accession
0001485003-16-000182
Insider Transaction Report
Form 4
DAN LESLIE
Director10% Owner
Transactions
- Award
Stock Option
2016-09-20+16,143→ 16,143 totalExercise: $3.37Exp: 2026-09-19→ Common Stock (16,143 underlying) - Award
Common Stock
2016-09-20+3,582,328→ 3,582,328 total(indirect: See Footnote)
Footnotes (3)
- [F1]The reporting person acquired 3,582,328 shares of issuer common stock in exchange for an 89.2585% interest in Viventia Bio Inc. pursuant to the issuer's purchase of all of the outstanding capital stock of Viventia Bio Inc. on September 20, 2016. Of the 3,582,328 shares issued to the reporting person in the transaction, 358,232 shares are currently being held in escrow and are subject to forfeiture during the 15-month period following the transaction to satisfy claims arising as a result of Viventia Bio Inc.'s or Clairmark Investments Ltd.'s breach of any of their respective representations, warranties or covenants in the share purchase agreement.
- [F2]The securities are directly held by Clairmark Investments Ltd. The Reporting Person is President and 100% shareholder of Clairmark Investments Ltd.
- [F3]This option was granted on September 20, 2016 and vests over three years with 1/36th of the shares subject to the option vesting at the end of each successive one-month period following the date of grant.
Documents
Issuer
Eleven Biotherapeutics, Inc.
CIK 0001485003
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001485003
Filing Metadata
- Form type
- 4
- Filed
- Sep 21, 8:00 PM ET
- Accepted
- Sep 22, 5:04 PM ET
- Size
- 7.7 KB